| 注册
首页|期刊导航|中国当代医药|局部进展期胃癌术后同步放化疗近期疗效与毒副作用分析

局部进展期胃癌术后同步放化疗近期疗效与毒副作用分析

王燕 许刚 吴立广 吴朝阳

中国当代医药Issue(13):8-11,4.
中国当代医药Issue(13):8-11,4.

局部进展期胃癌术后同步放化疗近期疗效与毒副作用分析

Analysis of short-term effect and toxic and side effect by concurrent ra-diochemotherapy after surgery of locally advanced gastric carcinoma

王燕 1许刚 1吴立广 1吴朝阳1

作者信息

  • 1. 江苏大学附属人民医院肿瘤放疗科,江苏镇江 212002
  • 折叠

摘要

Abstract

Objective To explore the influence of 2-year survival rate and short-term toxic and side effects in patients with stage II-Ⅲ gastric cancer after surgeries by concurrent radiochemotherapy and only chemotherapy. Methods 49II-Ⅲ stage gastric cancer patients admitted into our hospital and undergone radical operation from February 2010 to June 2012 were retrospectively analyzed.According to different therapeutic regimens,they were divided into two groups:concurrent radiochemotherapy after surgery group and only chemotherapy after surgery group.In the former group(n=24), XELOX regimen of chemotherapy was used for two weeks,and oral administration of capecitabine (825 mg/m2)twice per day for radiotherapy,and finally for two-week chemotherapy after radiotherapy was finished.In the latter one (n=25, XELOX regimen of chemotherapy was adopted for 4 to 6 weeks.The 2-year survival rate,survival rate without recur-rence,toxic and side effects during treatment were compared by regular follow up. Results The 2-year survival rate in concurrent chemoradiotherapy group and only chemotherapy group was 87.5% and 64.0% respectively.The survival rate of recurrence-free within 2 years in both groups was 70.8%and 48.0% respectively,with statistical difference (P<0.05). There was no significant difference in hematological toxicity,gastrointestinal reaction and hand-foot syndrome between two groups. Conclusion Concurrent chemoradiotherapy after operation for gastric carcinoma at stages ofII-Ⅲ can im-prove 2-year survival rate and survival rate of recurrence-free with tolerant toxic and side effect.

关键词

胃癌/术后同步放化疗/术后化疗/2年生存率/毒副作用

Key words

Gastric cancer/Concurrent chemoradiotherapy after surgery/Postoperative chemotherapy/2-year survival rate/Toxic and side effect

分类

医药卫生

引用本文复制引用

王燕,许刚,吴立广,吴朝阳..局部进展期胃癌术后同步放化疗近期疗效与毒副作用分析[J].中国当代医药,2015,(13):8-11,4.

基金项目

江苏省镇江市科学技术成果项目 ()

中国当代医药

1674-4721

访问量0
|
下载量0
段落导航相关论文